Galmed Pharmaceuticals Ltd (GLMD.OQ)
6.09USD
20 Apr 2018
$-0.18 (-2.87%)
$6.27
$6.25
$6.25
$6.07
2,253
18,319
$12.00
$3.61
Latest Key Developments (Source: Significant Developments)
Galmed Pharmaceuticals Files For Mixed Shelf Of Upto $150 Mln
March 26 (Reuters) - Galmed Pharmaceuticals Ltd
Galmed Pharmaceuticals Q4 Loss Per Share $0.27
March 13 (Reuters) - Galmed Pharmaceuticals Ltd
683 Capital Management Llc Reports 5.1 Pct Passive Stake In Galmed Pharmaceuticals Ltd As Of Dec 6
Dec 18 (Reuters) - Galmed Pharmaceuticals Ltd
Galmed Pharmaceuticals Q3 loss per share $0.23
Nov 9 (Reuters) - Galmed Pharmaceuticals Ltd
Galmed Pharmaceuticals signed agreement with University of California
Galmed Pharmaceuticals Ltd : Signed an investigator-initiated clinical trial agreement with University of California, San Diego, school of medicine .Artisan study is currently expected to be initiated in first half of 2017. Full Article
Galmed Pharmaceuticals Q2 loss per share $0.39
Galmed Pharmaceuticals Ltd
Galmed and Samil Pharm sign deal for Aramchol(Tm) in Korea
Galmed Pharmaceuticals Ltd : Galmed Pharmaceuticals And Samil Pharm sign a license agreement for the commercialization of aramchol(tm) in Korea . Upon signing of agreement, samil will pay galmed an up-front fee of approximately $2.0 million .Samil has also agreed to pay additional clinical- and regulatory-based milestone payments, which may aggregate to $6.0 million. Full Article
Galmed Pharmaceuticals says enters research collaboration agreement
Galmed Pharmaceuticals Ltd : Has right to enter into exclusive negotiations with Yeda to complete license agreement to commercialize diagnostic, prognostic tool for Aramchol .Galmed Pharmaceuticals and Weizmann Institute of Science to enter a research collaboration agreement to assess Aramchol(tm) effects on microbiome. Full Article
Galmed Pharmaceuticals posts Q1 loss of $0.36 per share
Galmed Pharmaceuticals Ltd
BRIEF-Galmed Pharmaceuticals Announces Pricing Of $6 Mln Registered Direct Offering
* ANNOUNCES PRICING OF $6.0 MILLION REGISTERED DIRECT OFFERING